Design-Zyme LLC
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.0Mattributed |
|---|---|
| Latest round | grant, $3.0M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | Lawrence, Kansas |
| Industry | unknown |
| Stage | unknown |
| Website | design-zyme.com |
Patented carbohydrate-based vaccine adjuvant platform with oral, nasal, and mucosal delivery routes. Sold to vaccine partners targeting opioid use disorder, Lyme disease, and fescue toxicosis. Partners include Wellcome Leap, University of Kansas, and Caltech.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $3.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress 7.0, PHP, WordPress Block Editor, WordPress Site Editor, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | design-zyme.com, read 2026-05-02 |
| Description | self-reported | design-zyme.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.